October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...
Mayo Clinic study shows stool DNA testing for colorectal cancer has potential, but challenges remain
ROCHESTER, Minn. -- The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of Annals of ...
Fecal occult blood testing (FOBT) has been proposed as an alternative to colonoscopic screening for the detection of colorectal cancer, but requires multiple stool samples because occult bleeding is ...
Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...
The American Cancer Society, U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology have published joint guidelines on screening and surveillance for early detection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results